These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 36389673)

  • 1. Impact of Epstein-Barr virus infection in patients with inflammatory bowel disease.
    Zhang H; Zhao S; Cao Z
    Front Immunol; 2022; 13():1001055. PubMed ID: 36389673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and endoscopic complications of Epstein-Barr virus in inflammatory bowel disease: an illustrative case series.
    Goetgebuer RL; van der Woude CJ; de Ridder L; Doukas M; de Vries AC
    Int J Colorectal Dis; 2019 May; 34(5):923-926. PubMed ID: 30739187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review on co-existent Epstein-Barr virus-induced complications in inflammatory bowel disease.
    Wu S; He C; Tang TY; Li YQ
    Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1085-1091. PubMed ID: 31205127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Epstein-Barr virus infection on inflammatory bowel disease (IBD) clinical outcomes.
    Núñez Ortiz A; Rojas Feria M; de la Cruz Ramírez MD; Gómez Izquierdo L; Trigo Salado C; Herrera Justiniano JM; Leo Carnerero E
    Rev Esp Enferm Dig; 2022 May; 114(5):259-265. PubMed ID: 34315215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus in inflammatory bowel disease: the spectrum of intestinal lymphoproliferative disorders.
    Nissen LH; Nagtegaal ID; de Jong DJ; Kievit W; Derikx LA; Groenen PJ; van Krieken JH; Hoentjen F
    J Crohns Colitis; 2015 May; 9(5):398-403. PubMed ID: 25740811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory inflammatory bowel disease: is there a role for Epstein-Barr virus? A case-controlled study using highly sensitive Epstein-Barr virus-encoded small RNA1 in situ hybridization.
    Pezhouh MK; Miller JA; Sharma R; Borzik D; Eze O; Waters K; Westerhoff MA; Parian AM; Lazarev MG; Voltaggio L
    Hum Pathol; 2018 Dec; 82():187-192. PubMed ID: 30120969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus associated colitis in kidney transplant patients: a case series.
    Brás AC; Querido S; Mascarenhas A; Mendes R; Verissimo R; Chagas C; Weigert A
    Infect Dis (Lond); 2024 May; 56(5):410-415. PubMed ID: 38459811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Status of Epstein-Barr Virus Infection in Intestinal Mucosa of Chinese Patients with Inflammatory Bowel Disease.
    Li X; Chen N; You P; Peng T; Chen G; Wang J; Li J; Liu Y
    Digestion; 2019; 99(2):126-132. PubMed ID: 30235444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement.
    Ciccocioppo R; Racca F; Paolucci S; Campanini G; Pozzi L; Betti E; Riboni R; Vanoli A; Baldanti F; Corazza GR
    World J Gastroenterol; 2015 Feb; 21(6):1915-26. PubMed ID: 25684960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-positive mucocutaneous ulcer arising in a post-hematopoietic cell transplant patient followed by polymorphic posttransplant lymphoproliferative disorder and cytomegalovirus colitis.
    Satou A; Kohno A; Fukuyama R; Elsayed AA; Nakamura S
    Hum Pathol; 2017 Jan; 59():147-151. PubMed ID: 27569297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter, cross-sectional, observational study on Epstein-Barr viral infection status and thiopurine use by age group in patients with inflammatory bowel disease in Japan (EBISU study).
    Miura M; Shimizu H; Saito D; Miyoshi J; Matsuura M; Kudo T; Hirayama D; Yoshida M; Arai K; Iwama I; Nakase H; Shimizu T; Hisamatsu T
    J Gastroenterol; 2021 Dec; 56(12):1080-1091. PubMed ID: 34591171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease.
    Gehlert T; Devergne O; Niedobitek G
    J Med Virol; 2004 Jul; 73(3):432-8. PubMed ID: 15170639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two rare cases of Epstein-Barr virus-associated lymphoproliferative disorders in inflammatory bowel disease patients on thiopurines and other immunosuppressive medications.
    Subramaniam K; Cherian M; Jain S; Latimer M; Corbett M; D'Rozario J; Pavli P
    Intern Med J; 2013 Dec; 43(12):1339-42. PubMed ID: 24330365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease.
    de Francisco R; Castaño-García A; Martínez-González S; Pérez-Martínez I; González-Huerta AJ; Morais LR; Fernández-García MS; Jiménez S; Díaz-Coto S; Flórez-Díez P; Suárez A; Riestra S
    Aliment Pharmacol Ther; 2018 Oct; 48(7):723-730. PubMed ID: 30095176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr Virus Status and Subsequent Thiopurine Exposure Within a Paediatric Inflammatory Bowel Disease Population.
    Harris RE; Hegde V; Curtis L; Garrick V; Gervais L; Armstrong L; Delahunty C; Eccleston A; Al-Hourani G; Flynn DM; Merrick V; Barclay AR; Tayler R; Hansen R; Russell RK
    J Pediatr Gastroenterol Nutr; 2021 Sep; 73(3):358-362. PubMed ID: 34091548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic lymphocytic infiltration with pontine perivascular enhancement responsive to steroids (CLIPPERS) and its association with Epstein-Barr Virus (EBV)-related lymphomatoid granulomatosis: a case report.
    Dang YL; Kok HK; McKelvie PA; Ligtermoet M; Maddy L; Burrows DA; Crompton DE
    BMC Neurol; 2021 Feb; 21(1):80. PubMed ID: 33602163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression for inflammatory bowel disease does not influence Epstein-Barr viral load in the short-term.
    Rodríguez-Lago I; Merino O; López de Goicoechea MJ; Aranzamendi M; Zubiaurre L; Muro N; Ortiz de Zárate J; Cilla G; Cabriada JL
    Gastroenterol Hepatol; 2019 Nov; 42(9):542-547. PubMed ID: 31402179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel disease exacerbation associated with Epstein-Barr virus infection.
    Dimitroulia E; Pitiriga VC; Piperaki ET; Spanakis NE; Tsakris A
    Dis Colon Rectum; 2013 Mar; 56(3):322-7. PubMed ID: 23392146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoid and myeloid proliferative disorders associated with inflammatory bowel disease: a clinicopathological study of 15 cases.
    Hori Y; Yamamoto H; Kawatoko S; Nozaki Y; Torisu T; Kato K; Koga Y; Miyoshi H; Ohshima K; Tateishi Y; Nakamura S; Kitazono T; Oda Y
    Hum Pathol; 2022 Feb; 120():88-98. PubMed ID: 34990621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantial Epstein-Barr virus reactivation in a case of severe refractory ulcerative colitis: a possible role in exacerbation.
    Kato S; Shimizu H; Tomii S; Uchida H; Kawamoto A; Hibiya S; Motobayashi M; Takenaka K; Fujii T; Saito E; Nagahori M; Ohtsuka K; Negi M; Akashi T; Matsuyama T; Kinugasa Y; Watanabe M
    Clin J Gastroenterol; 2021 Apr; 14(2):584-588. PubMed ID: 33400186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.